USE OF NADPH OXIDASE INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION OF ATHEROSCLEROSIS

• 1. NADPH氧化酶2抑制剂在制备药物中的用途 [P] . 中国专利： CN114129732A . 2022-03-04
• 2. 培氟沙星在制备治疗和预防高血脂药物或动脉粥样硬化药物中的用途 [P] . 中国专利： CN110327340A . 2019-10-15
• 3. USE OF NADPH OXIDASE INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION OF ATHEROSCLEROSIS [P] . CA2238098C . 2001-01-30

  机译： NADPH氧化酶抑制剂在制备预防动脉粥样硬化的药物中的用途

• 4. use of inhibitors of nadph oxidase for the manufacture of a medicament for the prevention of atherosclerosis [P] . DK0861070T3 . 2000-07-31

  机译： nadph氧化酶抑制剂在制备预防动脉粥样硬化的药物中的用途

• 5. USE OF NADPH OXIDASE INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION OF ATHEROSCLEROSIS [P] . 欧洲知识产权局专利： EP0861070B1 . 2000-03-01

  机译： NADPH氧化酶抑制剂在制备预防动脉粥样硬化的药物中的用途

• 1. Treatment with NADPH oxidase inhibitor apocynin alleviates diabetic neuropathic pain in rats [J] . Murat Olukman, Aytül (O)nal, Fatma Gül (C)elenk, 中国神经再生研究（英文版） . 2018,第009期
• 2. Cardioprotective Effects of Cell Permeable NADPH Oxidase Inhibitors in Myocardial Isehemia/Reperfusion (I/R) Injury [C] . Issachar Devine, Qian Chen, Regina Ondrasik American Peptide Symposium . 2013
• 3. Reduction of Angiotensin II Induced Hypertension and Cardiac Fibrosis with GLP-1 Receptor Agonist and DPP-4 Inhibitor via Decreasing NADPH Oxidase Expression [D] . Banks, Trenton Edward. 2020
• 4. Protective action of NADPH oxidase inhibitors and role of NADPH oxidase in pathogenesis of colon inflammation in mice [O] . Rima Ramonaite, Jurgita Skieceviciene, Simonas Juzenas, 2014
• 5. Impaired Superoxide Production Due to a Deficiency in Phagocyte NADPH Oxidase Fails to Inhibit Atherosclerosis in Mice [O] . Elizabeth A. Kirk, Mary C. Dinauer, Henry Rosen, 2000

• 1. Protective action of NADPH oxidase inhibitors and role of NADPH oxidase in pathogenesis of colon inflammation in mice [J] . Rima Ramonaite ,Jurgita Skieceviciene ,Simonas Juzenas . 世界胃肠病学杂志：英文版 . 2014,第35期
• 2. Effect of NADPH Oxidase Inhibitor Apocynin on the Expression of Hypoxia-induced Factor-1α and Endothelin-1 in Rat Carotid Body Exposed to Chronic Intermittent Hypoxia [J] . Xue LIU ,Yan DENG ,Jin SHANG . 华中科技大学学报（医学）（英德文版） . 2013,第002期
• 3. Tolerance of Soybean(Glycine max L.)to Protoporphyrinogen Oxidase Inhibitors and Very Long Chain Fatty Acid Synthesis Inhibitors Applied Preemergence [J] . Kris J.Mahoney ,Francois J.Tardif ,Darren E.Robinson . 美国植物学期刊（英文） . 2014,第8期
• 4. Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients [J] . Rui Zhang ,Danielle C. Spengler ,Marie-Helene Saint-Hilaire . 帕金森（英文） . 2012,第1期
• 5. NADPH氧化酶在动脉粥样硬化发生和发展过程中的作用 [C] . 黎健 . 第八届中国南方国际心血管病学术会议 . 2006
• 6. HO-1,NADPH氧化酶在动脉粥样硬化性肾动脉狭窄肾组织中表达及药物干预 [A] . 韩玉祯 . 2012